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Penelitian Klinik
Surgical Risk for Adult with Tetralogy of Fallot
Karina V. Wilamarta, Dicky Fakhri, Jusuf Rachmat
Background. The beneficiaries of successful pediatric cardiac surgery and
cardiology increases surgical treatment in the adult population with
congenital heart disease. Adults patient with Tetralogy of Fallot (TOF) will
need surgery either reoperative, palliative or more commonly reparative
by the time they come. Many of them face the prospect of further
operations, arrhythmias, complications and if managed inappropriately will
increase risk of heart failure and premature death. This study presents the
early surgical results of adult TOF.
Methods and results. Data were reviewed retrospectively related to the
hospital course of TOF adult patients (age > 17 years) from June 1, 1998
to December 30, 2006 who require surgical treatment in National Cardiac
Center - Harapan Kita, Indonesia. Most of the operations were corrective
procedures (20 patients, 66.7%), followed by palliative procedures (6
patients, 20%), and reoperations (4 patients, 13.3%). Mean age at surgery
was 20.87+5.49 years. There were no hospital mortality in the primary
corrective group, one death (16.7) in the palliative group related to poor
left ventricular function, and one death (25%) in the reoperation group
related to perioperative bleeding. Follow up data of 11.73+17.68 months
duration were available in 28 of 30 patients (93%) who were discharged
home. Overall survival probability is higher for corrective procedures than
palliative and reoperative procedures.
Conclusions. Surgical treatment of TOF in adult patients proved quite
save and beneficial
(J Kardiol Ind 2007;28:197-202)
Keywords:  Adult Tetralogy of Fallot, palliative procedures, corrective procedures,
reoperations.
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Clinical Research
The number of patients with adult congenital heart
disease (ACHD) is expected to increase during this
decade.1 Surgery for ACHD as a result of primary repair
of CHD within the pediatric age group is still
challenging. Although the outlook for patients with
CHD has been transformed, most early interventions
have not been curative. It is estimated that approximately
50% of ACHD patients face the prospect of further
Latar Belakang. Keberhasilan bedah jantung anak telah membawa manfaat besar bagi populasi dewasa dengan penyakit
jatung bawaan. Pasien dewasa dengan Tetralogi Fallot (TF) akan memerlukan tindakan bedah, mungkin reoperasi, bedah
paliatif atau yang paling sering bedah reparatif/korektif. Bila tidak ditangani dengan baik, kebanyakan pasien ini akan menghadapi
masalah bedah berulang, aritmia, gagal jantung dan kematian dini. Penelitian ini mempresentasikan hasil dini bedah pada
pasien dewasa dengan TF.
Metode dan hasil. Data rekam medis pasien dewasa dengan TF (usia 17 tahun atau lebih) yang menjalani pembedahan di
Pusat jantung Nasional – Harapan Kita, Jakarta, Indonesia dalam periode 1 Juni 1998 sampai dengan 30 Desember 2006
dipelajari secara retrospektif. Sebagian terbesar telah dilakukan bedah korektif (20 pasien, 68%), diikuti dengan bedah paliatif
(6 pasien, 20%), dan reoperasi (4 pasien, 13.3%). Usia rerata saat bedah adalah 20.87+5.49 tahun. Tak ada kematian pada
kelompok bedah korektif primer. Satu kematian terjadi pada 6 kasus yang menjalani bedah paliatif (16.7%), dan satu kematian
(25%) terjadi pada 4 kasus yang menjalani reoperasi pasca bedah paliatif sebelumnya. Data evaluasi lebih lanjut didapat dari
28 pasien (93%) yang diikuti selama periode rerata 11.73+17.68 bulan. Probabilitas survival keseluruhan lebih tinggi pada
kelompok bedah korektif dibanding kelompok paliatif dan reoperasi.
Kesimpulan. Pembedahan pada pasien dewasa dengan TF terbukti aman dan bermanfaat.
Kata Kunci: Tetralogi Fallot dewasa, bedah paliatif, bedah korektif, reoperasi.
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surgery, arrhythmia, heart failure and - if managed
inappropriately – of premature death.2,3
Surgery for Tetralogy of Fallot (TOF) as a benchmark
of cyanotic type congenital cardiac surgery has been chosen
to be analyzed. Adult patients with TOF will have had
surgery either reoperative, palliative or more commonly
reparative by the time they come. The objective of this
study is to present the early surgical results of patients who
require surgery for TOF in the adult population.
Material and Methods
We reviewed the medical records of adult patients (aged
17 years or older) who underwent cardiac operations at
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the National Cardiovascular Centre - Harapan Kita
Hospital, Jakarta-indonesia, from June 1, 1998, through
December 31, 2006.
Cardiac rhythm, preoperative risk factors, extracardiac
anomalies, and postoperative complications were
identified as risk factors. For analysis, surgical procedures
were divided into three categories, including the following:
(1) palliative procedures; (2) corrective procedures; and
(3) reoperations. Palliative procedures include all
operations performed to improve the patient’s clinical
status. Corrective procedures are operations employed to
achieve an anatomical or physiologic correction with
separation of the pulmonary from systemic circulation.
Results are presented as mean and standard deviation
(median and range were used if data were not normally
distributed). Comparisons of continuous variables were
performed by Welch,s t-test. P value greater than 0.05
means that difference between groups is not statistically
significant. To assess if there was a statistical significance
between groups, data were analyzed with analysis of
variance. Multiple comparison test was further employed
to assess statistical significance between groups. Overall
survival probability, as well as survival probability for
different surgical categories (palliative procedures,
corrective procedures, and reoperation), were analyzed
according to Kaplan–Meier method.
Results
Thirty patients (>17 years of age) requiring surgical
treatment for TOF were included in this study which
is consist of 13 males and 17 females. Mean age at
surgery was 20.87+5.49 years. Extra cardiac anomalies
were identified in 5 patients and other intracardiac
anomalies were found in 4 patients. Preoperative
diagnosis was achieved by echocardiography and
cardiac catheterization.
According to preoperative clinical evaluation, 28
patients belonged to New York Heart Association
(NYHA) class I-II, 2 in NYHA class III. Sinus rhythm in
20 of 30 patients (67%) was revealed in electro-
cardiogram. Arrhythmia were present in the remaining
10 patients and including Right Bundle Branch Block
(RBBB) 7 patients, Ventricular Extra Systole (VES) 3
patients, sinus bradycardia 1 patient. Preoperative variables
which are commonly associated to an increase hospital
morbidity and mortality were identified in 7 patients,
being multiple in 2 patients. Preoperative arrhythmia and
preoperative NYHA class III-IV were the only causes
linked to increasing hospital mortality.
 Major postoperative complications occurred in 10
patients (30%). Seven patients presented multiple
complications (Table 1). Pulmonary insufficiency and
right ventricular dysfunction were measured by
echocardiography following intracardiac repair, with
10 patients mild pulmonary stenosis (PS), 7 patients




Low output syndrome 2
Pericardial effusion requiring drainage 1
Pleural effusion 1
Cardiac arrest 1
Neurological deficit persisting at discharge 1
Other postoperative complication 1
Table 2. Surgical Categories
Variables Analyzed Corrective Palliative Reoperations p Value
Procedures Procedures
Number of procedures 20(66.7%) 6 (20.0%) 4(13.3%)
Sex M/F 5/15 6/0 2/2 0.05
Mean age in years (SD) 20.35(5.81) 21.8 (4.02) 22.0(6.78) 0.78
Preoperative sinus rhythm 12(60%) 4 (66.7%) 2(50%) 0.87
Postoperative complications 3(15%) 6 (100.0%) 1(25%) 0.01
Sinus rhythm at discharge 18(90%) 4 (66.7%) 4(100%) 0.24
Mean ICU stay/days (SD) 0.78(0.55) 1.22(1.71) 0.62(0.44) 0.49
Mean hospital stay/days (SD) 15.40(8.93) 9.67(6.97) 9.75(6.40) 0.23
Hospital mortality (%) 0(0%) 1(16.5%) 1(25%) 0.10
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mild pulmonary insuffisiensi (PI) and 2 patients with
severe PI. Two patients with moderate to severe right
heart failure.
There were 2 hospital deaths (6.4%), one in the
palliative surgery group and one in the reoperation
group; no hospital death in the corrective group. The
most common causes of death were pump failure and
perioperative bleeding. Patients who underwent
corrective procedures presented with lower mortality
rate, requiring also less time in the intensive care unit
and a shorter total hospital stay, although is was not
significant (Table 2).
Follow up data were available in 28 of 30 patients
(93%) who were discharge from hospital. Reoperation
was necessary in 2 of 30 patients (6%) within a mean
time 3 months after hospital discharge. At a mean
follow-up time of 11.73+17.68 months 28 patients
(93%) were in NYHA I-II. Late death occurred in 1
patient (3%).  Survival probability according to
Kaplan–Meier showed an overall survival of 87.8% at
60 months (Figure 1). A follow-up analysis shows an
overall survival probability of 87.8% at 60 months,
which is higher for corrective procedures (92.3%) if
compared with reoperations (75%) and palliations
(83.3%) (Figure 2).
The significant p value is postoperative
complications (p<0.05), and there are no statistically
significantly different in the multiple comparison
(Bonferroni) test for mean comparison.
Discussion
Patients with CHD who reach the adult age usually
remain in good or mildly decreased functional status
for several years and are eventually referred to surgical
treatment because of increasing symptoms not
controlled by medical therapy. The majority of these
patients survived into adult age in good functional
status, considering that 93.3 % of them were
preoperative NYHA class I or II. They are a selected
group of patients mainly composed by individuals who
have survived into adult age without irreversible
damage to their heart and lung. Our data suggest that
adult TOF patient with good functional capacity
(NYHA class I-II), the hospital outcome can be better
when compared to that of patients who presented with
worse functional status (NYHA class III-IV).
The overall hospital mortality for TOF repairs in
our centre during three years period (2003-2005,
N=273) was 6.23%, comparable to the 5% mortality
rate from the European Congenital Database. In our
series, there is no  hospital mortality for TOF repair
in adult. Palliative procedure was offered to our adult
TOF patient with poor left ventricular function, to
improve the clinical condition at least temporarily.
In our series there were 6 cases who had palliative
procedure, with hospital mortality of 16.7% (1
patient). Although the operations achieved a decrease
on cyanosis, we have no long-term functional results
of these patients. Reoperation after a previous
palliative procedure to enlarge pulmonary artery,
Figure 2. Kaplan-Meier survival function by type of surgery
(palliations , corrections, reoperation). Survival in 60
months probability in total correction type is 92.31% with
95% confidence bands (0.57-0.99), in reoperation type is
75% with 95% confidence bands (0.13-0.96) and  in
palliation type is 83.33% with 95% confidence bands (0.27-
0.97)
Figure 1. Overall survival probability according to Kaplan-
Meier function with 95% confidence bands. Overall survival
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carried a high mortality rate (one out of 4 patients,
25%). The cause of death was related to perioperative
bleeding. We have no reoperation related to conduit
placement or pulmonary valve replacement after
initial correction. The better outcome in the
corrective group possibly related to the better
condition of the patients.
Deterioration of RV function and exercise capacity
correlate with a longer interval since repair, but these
moderate associations can not be used to predict the
pace of decline in the individual patients. Improvement
of clinical condition may be obtained by improving
right ventricle outflow tract (RVOT) function
preservation during surgery, and by reducing the effect
of electrical inhomogenicity for long term outcome of
TOF.5  The oldest patient in our series is a 42 years
old patient with poor right ventricular function and
arrhythmia, the long term outcome in this particular
patient is also poor.
Optimal timing for reoperation pulmonary valve
replacement seems crucial, as the children became an
adult, the criteria so far have not been established. We
have seen this problem in a 26 years of age patient
with absent pulmonary valve. Shimazaki et.al6 showed
that in his series, beyond the age 30 to 40 progressively
more patients become symptomatic, with onset of right
heart failure.
A follow-up analysis shows an overall survival
probability of 87.8% at 60 months, which is higher
for corrective procedures (92.3%) if compared with
reoperations (75%) and palliations (83.3%). Although
palliative operations in these kinds of patients did
achieve a decrease cyanosis at low risk, but we have no
long-term functional results of these patients to allow
definitive conclusions. Reoperation after a palliative
procedures or previous corrective procedure includes
patients with either a residual lesion after correction
or patients who acquired secondary complications after
their initial correction. These group of patients show
the most difficult challenging, who need the premium
hands of congenital adult cardiac surgeon. It is
important to know the long term post-operative
functional results of these patients. Unfortunately we
were able to collect follow-up information only in 67%
of the patients, and limited to 60 months after the
operation (mean of 11.73 + 17.68 months). The reason
for this limitation is related to the patients social
economy condition, most of them  were referred from
peripheral suburban area, no proper follow up could
be performed.
Continuous evaluation of the quality of care
become one of the highest priorities in modern surgical
practice.7 Especially, in the field of Congenital Heart
Surgery (CHS), where adverse outcomes can be
frequent due to the wide spectrum of congenital cardiac
conditions and severity of pathologies, as well as high
proportion of palliations.8,9 It is obvious that 30 days
mortality measure carries important limitation for
assessment of residual pulmonary regurgitation or
stenosis, arrhythmia and ventricular failure.
According to the Good Clinical Practice
guidelines defined and recommended by World
Health Organization (WHO), all database contents
should be verified by comparison with the original
records at the site of their origin-Source Data
Verification (SDV).10,11  Two patients, out of thirty
after verification, have been missed. There have been
no statistically significant differences between
preoperative sinus rhythm and rhythm at discharge.
Undoubtedly, modern intensive care technology
extends critical patients survival time what does not
necessarily mean increase in long-term survival and
improvement of the quality of life. All congenital
cardiac surgery 30 days mortality was 3.58%12.
Conclusions.
Surgical treatment for Tetralogy of Fallot in adult
patients at the National cardiovascular Centre Jakarta-
Indonesia is quite save and beneficial; a well organized
long term follow up is needed. The care of adult
patients with corrected or uncorrected CHD is growing
and become a challenging new field for the cardiologist
in Indonesia
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